Non-compliance with oral hypoglycemic agents (OHA) is a central issue in patients of type II DM, as it decreases the efficacy of treatment and leads to development of long-term complications.The prescribed drugs are usually to be taken 20-30 minutes prior to a meal, which is ordinarily missed by patients resulting in the declining health of diabetic patients due to development of complications.As such, little data is available on compliance specifically to OHA in type II DM, but previous studies have reported it to be poor to satisfactory.